Investing.com -- GoodRx (NASDAQ:GDRX) stock fell 5% on Thursday after a CBS reporter indicated that the discount prescription drug platform would not be partnering with the upcoming TrumpRx initiative ...
Researchers at Moffitt Cancer Center have developed a novel biomaterial-based system that induces the formation of tertiary lymphoid-like structures (TLSs). These immune cell clusters are increasingly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback